yahoo_financeOriginal article
BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat
Data ReadoutnegativeNegative
AI Analysis
Summary
BioNTech's colorectal cancer vaccine trial failed, causing an 8% stock decline, while Moderna dropped 6% and Pfizer remained flat in market reaction to the negative clinical data.
Clinical Trial Data
Primary Endpoint
Not Met
Outcome Details
Colorectal cancer vaccine trial failed
Importance:7/10
Sentiment:
-0.75
vaccineoncologyclinical_trialstock_decline
Read the original article
Published by yahoo_finance on August 28, 2026 2:58 PM